91ÖĆƬł§

Published on Market Research Reports® Inc. ()

Home > Global Tuberculosis (TB) Diagnostics Market Growth (Status and Outlook) 2025-2031

Global Tuberculosis (TB) Diagnostics Market Growth (Status and Outlook) 2025-2031

Publication ID: 
LPI08254074
Publication Date: 
August 6, 2025
Pages: 
92
Publisher: 
LPI
Countries: 
Global [1]
USD 3,660.00

Please choose the suitable license type from above. More details are given under tab "Report License Types" below.

Pharmaceutical Manufacturing [2]
Healthcare [3]
Pharma & Healthcare [4]
Description: 

According to this study, the global Tuberculosis (TB) Diagnostics market size will reach US$ 4099 million by 2031.
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
The global TB diagnostics market is being propelled by the urgent need to improve disease detection and control in response to the persistent burden of tuberculosis, particularly in high-prevalence regions. Efforts to reach WHO’s End TB goals have elevated funding for TB programs, driving the rollout of advanced diagnostic tools like molecular assays , X‑ray based screening solutions with AI assistance, and point-of-care tests. Furthermore, increasing integration of TB screening within broader healthcare initiatives—such as universal healthcare coverage and integrated respiratory disease programs—has expanded testing capacity. The push to screen high-risk populations, including people living with HIV, healthcare workers, migrants, and prison inmates, has also increased demand for rapid, accurate, and decentralized diagnostic methods capable of delivering same-day results and guiding treatment decisions.
Despite significant advancements in TB diagnostics, substantial barriers continue to hinder market expansion. One major challenge is inconsistent access to cutting-edge diagnostic tools in low- and middle-income countries, where infrastructure remains limited and centralized laboratory systems struggle to support widespread deployment. Additionally, the cost of advanced molecular and imaging technologies remains a deterrent, particularly when factoring in expenses for equipment maintenance, consumables, and the specialized training required for healthcare personnel. The regulatory and logistical complexities involved in distributing diagnostic platforms—especially in remote rural areas—also slow down adoption. Finally, the co-existence of disparate diagnostic algorithms across countries, combined with variable healthcare funding and weak supply chain systems, continues to limit consistent implementation of guideline-compliant testing and undermines efforts to significantly reduce TB incidence.
Global Tuberculosis (TB) Diagnostics key players include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, etc. Global top five manufacturers hold a share about 33%. APAC is the largest market, with a share over 40%, followed by Americas and Europe, both have a share about 40 percent.
The “Tuberculosis (TB) Diagnostics Industry Forecast” looks at past sales and reviews total world Tuberculosis (TB) Diagnostics sales in 2024, providing a comprehensive analysis by region and market sector of projected Tuberculosis (TB) Diagnostics sales for 2025 through 2031. With Tuberculosis (TB) Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tuberculosis (TB) Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global Tuberculosis (TB) Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Tuberculosis (TB) Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tuberculosis (TB) Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tuberculosis (TB) Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tuberculosis (TB) Diagnostics.
This report presents a comprehensive overview, market shares, and growth opportunities of Tuberculosis (TB) Diagnostics market by product type, application, key players and key regions and countries.
Segmentation by Type:
Culture-Based Diagnostics
Sputum Smear Microscopy
Rapid Molecular Diagnostics
Others
Segmentation by Application:
Diagnostic Laboratories
Hospitals
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Danaher
Roche
Thermo Fisher Scientific
BD
Abbott
Hologic
Qiagen
BioMerieux
Hain Lifescience
Oxford Immunotec

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents: 

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Tuberculosis (TB) Diagnostics Market Size (2020-2031)
2.1.2 Tuberculosis (TB) Diagnostics Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Tuberculosis (TB) Diagnostics by Country/Region (2020, 2024 & 2031)
2.2 Tuberculosis (TB) Diagnostics Segment by Type
2.2.1 Culture-Based Diagnostics
2.2.2 Sputum Smear Microscopy
2.2.3 Rapid Molecular Diagnostics
2.2.4 Others
2.3 Tuberculosis (TB) Diagnostics Market Size by Type
2.3.1 Tuberculosis (TB) Diagnostics Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Tuberculosis (TB) Diagnostics Market Size Market Share by Type (2020-2025)
2.4 Tuberculosis (TB) Diagnostics Segment by Application
2.4.1 Diagnostic Laboratories
2.4.2 Hospitals
2.5 Tuberculosis (TB) Diagnostics Market Size by Application
2.5.1 Tuberculosis (TB) Diagnostics Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Tuberculosis (TB) Diagnostics Market Size Market Share by Application (2020-2025)
3 Tuberculosis (TB) Diagnostics Market Size by Player
3.1 Tuberculosis (TB) Diagnostics Market Size Market Share by Player
3.1.1 Global Tuberculosis (TB) Diagnostics Revenue by Player (2020-2025)
3.1.2 Global Tuberculosis (TB) Diagnostics Revenue Market Share by Player (2020-2025)
3.2 Global Tuberculosis (TB) Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Tuberculosis (TB) Diagnostics by Region
4.1 Tuberculosis (TB) Diagnostics Market Size by Region (2020-2025)
4.2 Global Tuberculosis (TB) Diagnostics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Tuberculosis (TB) Diagnostics Market Size Growth (2020-2025)
4.4 APAC Tuberculosis (TB) Diagnostics Market Size Growth (2020-2025)
4.5 Europe Tuberculosis (TB) Diagnostics Market Size Growth (2020-2025)
4.6 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size Growth (2020-2025)
5 Americas
5.1 Americas Tuberculosis (TB) Diagnostics Market Size by Country (2020-2025)
5.2 Americas Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025)
5.3 Americas Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tuberculosis (TB) Diagnostics Market Size by Region (2020-2025)
6.2 APAC Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025)
6.3 APAC Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Tuberculosis (TB) Diagnostics Market Size by Country (2020-2025)
7.2 Europe Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025)
7.3 Europe Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Tuberculosis (TB) Diagnostics by Region (2020-2025)
8.2 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025)
8.3 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Tuberculosis (TB) Diagnostics Market Forecast
10.1 Global Tuberculosis (TB) Diagnostics Forecast by Region (2026-2031)
10.1.1 Global Tuberculosis (TB) Diagnostics Forecast by Region (2026-2031)
10.1.2 Americas Tuberculosis (TB) Diagnostics Forecast
10.1.3 APAC Tuberculosis (TB) Diagnostics Forecast
10.1.4 Europe Tuberculosis (TB) Diagnostics Forecast
10.1.5 Middle East & Africa Tuberculosis (TB) Diagnostics Forecast
10.2 Americas Tuberculosis (TB) Diagnostics Forecast by Country (2026-2031)
10.2.1 United States Market Tuberculosis (TB) Diagnostics Forecast
10.2.2 Canada Market Tuberculosis (TB) Diagnostics Forecast
10.2.3 Mexico Market Tuberculosis (TB) Diagnostics Forecast
10.2.4 Brazil Market Tuberculosis (TB) Diagnostics Forecast
10.3 APAC Tuberculosis (TB) Diagnostics Forecast by Region (2026-2031)
10.3.1 China Tuberculosis (TB) Diagnostics Market Forecast
10.3.2 Japan Market Tuberculosis (TB) Diagnostics Forecast
10.3.3 Korea Market Tuberculosis (TB) Diagnostics Forecast
10.3.4 Southeast Asia Market Tuberculosis (TB) Diagnostics Forecast
10.3.5 India Market Tuberculosis (TB) Diagnostics Forecast
10.3.6 Australia Market Tuberculosis (TB) Diagnostics Forecast
10.4 Europe Tuberculosis (TB) Diagnostics Forecast by Country (2026-2031)
10.4.1 Germany Market Tuberculosis (TB) Diagnostics Forecast
10.4.2 France Market Tuberculosis (TB) Diagnostics Forecast
10.4.3 UK Market Tuberculosis (TB) Diagnostics Forecast
10.4.4 Italy Market Tuberculosis (TB) Diagnostics Forecast
10.4.5 Russia Market Tuberculosis (TB) Diagnostics Forecast
10.5 Middle East & Africa Tuberculosis (TB) Diagnostics Forecast by Region (2026-2031)
10.5.1 Egypt Market Tuberculosis (TB) Diagnostics Forecast
10.5.2 South Africa Market Tuberculosis (TB) Diagnostics Forecast
10.5.3 Israel Market Tuberculosis (TB) Diagnostics Forecast
10.5.4 Turkey Market Tuberculosis (TB) Diagnostics Forecast
10.6 Global Tuberculosis (TB) Diagnostics Forecast by Type (2026-2031)
10.7 Global Tuberculosis (TB) Diagnostics Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Tuberculosis (TB) Diagnostics Forecast
11 Key Players Analysis
11.1 Danaher
11.1.1 Danaher Company Information
11.1.2 Danaher Tuberculosis (TB) Diagnostics Product Offered
11.1.3 Danaher Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Danaher Main Business Overview
11.1.5 Danaher Latest Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche Tuberculosis (TB) Diagnostics Product Offered
11.2.3 Roche Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Roche Main Business Overview
11.2.5 Roche Latest Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Information
11.3.2 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product Offered
11.3.3 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Thermo Fisher Scientific Main Business Overview
11.3.5 Thermo Fisher Scientific Latest Developments
11.4 BD
11.4.1 BD Company Information
11.4.2 BD Tuberculosis (TB) Diagnostics Product Offered
11.4.3 BD Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 BD Main Business Overview
11.4.5 BD Latest Developments
11.5 Abbott
11.5.1 Abbott Company Information
11.5.2 Abbott Tuberculosis (TB) Diagnostics Product Offered
11.5.3 Abbott Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Abbott Main Business Overview
11.5.5 Abbott Latest Developments
11.6 Hologic
11.6.1 Hologic Company Information
11.6.2 Hologic Tuberculosis (TB) Diagnostics Product Offered
11.6.3 Hologic Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Hologic Main Business Overview
11.6.5 Hologic Latest Developments
11.7 Qiagen
11.7.1 Qiagen Company Information
11.7.2 Qiagen Tuberculosis (TB) Diagnostics Product Offered
11.7.3 Qiagen Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Qiagen Main Business Overview
11.7.5 Qiagen Latest Developments
11.8 BioMerieux
11.8.1 BioMerieux Company Information
11.8.2 BioMerieux Tuberculosis (TB) Diagnostics Product Offered
11.8.3 BioMerieux Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 BioMerieux Main Business Overview
11.8.5 BioMerieux Latest Developments
11.9 Hain Lifescience
11.9.1 Hain Lifescience Company Information
11.9.2 Hain Lifescience Tuberculosis (TB) Diagnostics Product Offered
11.9.3 Hain Lifescience Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Hain Lifescience Main Business Overview
11.9.5 Hain Lifescience Latest Developments
11.10 Oxford Immunotec
11.10.1 Oxford Immunotec Company Information
11.10.2 Oxford Immunotec Tuberculosis (TB) Diagnostics Product Offered
11.10.3 Oxford Immunotec Tuberculosis (TB) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Oxford Immunotec Main Business Overview
11.10.5 Oxford Immunotec Latest Developments
12 Research Findings and Conclusion

License Types: 

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

Ěý

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

Ěý

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Source URL:/lpi/global-tuberculosis-tb-diagnostics-market-growth-status-and-outlook-2025-2031

Links
[1] /countries/global[2] /pharmaceutical-manufacturing[3] /healthcare[4] /pharma-healthcare